Subject Index
air pollution
30, 33, 40–41, 45, 47–48, 213
alcohol
8, 30, 32, 35, 37–40, 42–44, 49–50, 213
bank location(s)
146, 149–151, 160
banking desert
146, 156, 160
biotechnology
71, 165, 172–173, 176–178, 210
body mass index (BMI)
33, 36
breast cancer
7–13, 15–16, 25–28, 112
breast cancer death rate(s)
11, 16
cancer incidence
1, 7–8, 13, 16–19, 21–22, 25–26, 29, 31–33, 43–44, 47–48, 212
cancer mortality
9, 16–17, 22, 24, 26–28, 30, 35–38, 40–41, 43, 51, 179
cancer prevention
9, 30–31, 33, 44, 46–48
Chicago
7–8, 26, 146–147, 149, 152–156, 160, 161
China
31, 165–183, 186–192, 194, 197, 213
cluster(s)
3, 30, 35–43, 45–46, 49–51, 173–174, 177, 212
clustering
11, 35, 42, 45–46, 51, 148
competitiveness
122–123, 125, 144, 173–175, 179, 181–185, 193–194
co-payments
80, 98
COVID-19 pandemic
1–2, 105, 166, 171, 180–182, 184–185, 192–194, 206, 208, 212–214
death rate(s)
11, 16, 40, 42
demand
84, 123–124, 126, 169, 171, 181
determinants of health
7–8, 24, 177, 212, 214
diet
31–33, 35, 38, 41, 43, 49, 51
disparities
1, 7–9, 13, 16–17, 21–29, 45, 48, 88, 149, 179, 212–214
economic assessment
110, 112
economic deprivation
146, 148, 150–152, 156, 160
economic efficiency
115–116
education
10–13, 15, 24–25, 38–41, 44, 46–47, 49–50, 95, 99, 138–140
effectiveness
1, 81, 89–90, 95, 98, 104–105, 108–109, 111–118, 126–127, 172, 176, 198–199, 201
efficiency
2, 75, 81, 84, 90–91, 93–95, 98, 100–101, 104–105, 108, 114–117, 122, 126, 130, 135–136, 170, 200–201, 204, 207, 213–214
emerging economies
165–166
epidemiology
7, 16–17, 22, 24–26, 28, 44–46, 67, 71
Europe 2020 strategy
125
European Union (EU)
30–31, 35–37, 41–46, 62, 64, 86, 100–102, 105, 109, 116, 118–119, 121–122, 125, 127–137, 139–141, 143–145, 165–171, 173, 175–177, 212–213
evaluation
34–35, 46, 61, 93, 97, 100, 109–110, 115, 118, 125–127, 130, 135, 137, 141, 143, 209–210, 214
fringe banking
148, 160
GDP
30, 35, 38–41, 43, 45, 48–51, 81–84, 87–89, 91, 96, 105, 111–114, 138, 167–168, 171, 173, 175–176
Germany
36, 37, 39, 42, 64, 75, 80–82, 86–87, 90, 92, 96, 103, 128–129, 142, 180–181, 183, 186, 188–193
government policy
123
health economics
98, 112, 177–178, 210–211
health equity
7, 16, 29
health disparities
8, 16, 24, 26–28, 48
health policy
1–2, 44, 46, 87, 89, 113, 178, 210, 214
health services
48, 76, 78, 88, 100, 105, 107, 114–115, 117, 195
healthcare/ health care
1–2, 17, 23, 30, 35, 38–43, 61, 67, 75–103, 104–111, 114–121, 126–127, 137–138, 147, 159, 165–172, 175–178, 181–183, 194–195, 212–214
healthcare system/ health care system(s)
1, 2, 23, 61, 75–101, 103–106, 108, 114–117, 165–167, 169–170, 175–176, 178, 182, 212–214
high-technology industries
165–166, 171, 176, 213
Horizon 2020 (H2020)
121–122, 125–132, 134–141, 143, 145
human capital
111, 179, 184, 194, 212
incidence rate
17, 19, 22, 63, 65
incubation period
55, 58
innovation
2, 25, 45, 91–92, 101, 106, 121–125, 138, 141–145, 165–166, 168, 171–179, 181–183, 193–194, 210, 221, 214
intellectual property
123, 183
key performance indicators (KPI)
104, 114–118, 130–131, 214
lifestyle
37, 40, 46, 95, 109, 168, 176
lung cancer
7–8, 13, 16–48, 51, 212–214
market
82, 122–124, 130–131, 135, 142, 145, 170, 172, 175, 176, 181–182, 188, 191, 194, 196–199, 205–208, 213
measurement
106–107, 120, 141, 146, 152–154, 156, 158, 194
measurement radius/radii
146, 152–154, 156, 158
medical admission(s)
18–22
medical product(s)
180–181, 184–192
medical treatment
1, 18
multinationals
182, 191
OLS regressions
151, 153, 156
personalized medicine (PM)
105, 108–114, 116, 118–119, 127, 138
pharmaceutical industry
2, 165, 166, 171–173, 175–178, 181–183, 194, 197, 209–201, 212–213
pharmaceutical sector
2, 166, 173–176, 182, 194, 210, 212, 214
pharmaceuticals
165–166, 171, 175–176, 180–184, 186–193, 213–214
Poland
2, 30, 36–37, 39, 41, 46, 75, 81–82, 88–90, 93, 96, 102, 105, 110, 113, 129, 165–173, 176–177, 183, 198
policy
1–3, 30–31, 34, 44, 46, 83, 87, 89, 101–102, 113, 119, 122–125, 141–145, 160, 173, 175, 177–179, 181–182, 193–194, 210, 214
public health
2, 24–25, 27–29, 44, 46–48, 52–53, 55–56, 61–62, 65–67, 69–70, 76, 80, 146–147, 158–159, 168–169, 171, 177–179, 182, 184, 193, 212–214
public health policies
182, 212
regression model(s)
3, 34, 40–41, 177
revealed comparative advantage (RCA)
180–181, 184–190, 192, 194
risk factor(s)
1, 7–8, 13, 18, 28, 30–35, 36, 40–47, 108, 212–214
Singapore
75, 81, 82, 85–86, 90, 92, 96, 98, 101–102, 183, 213
smoking
8, 16–18, 20–26, 29–30, 32–34, 37, 39–43, 45, 47, 213
societal challenges
122, 125, 130–131, 133, 135, 142
socioeconomic status (SES)
2, 7–10, 11, 13, 15, 16, 25, 30, 34, 35, 36, 39, 40, 41, 42, 43, 45, 46, 213
statistical method(s)
3, 146, 148
supply
60, 79, 124, 176, 184
Sweden
36–37, 39–40, 42–43, 46, 75, 79, 81–82, 87–88, 90, 93, 96–97, 99, 103, 129, 213–214
Switzerland
180–181, 183, 186, 188–193
trade
2, 145, 172, 179, 180–195, 212–213
Trade Intensity Index (TII)
181, 184, 185, 190–191
trade pattern(s)
181, 193
United Kingdom (UK)
75, 77, 79, 81–85, 90–92, 95–96, 100, 102–103, 128–129, 183, 188–190
United States (US)
7–10, 13, 16–17, 23–26, 28–29, 33–34, 46–47, 52, 54, 60–65, 70, 75, 77, 79, 81–83, 90–93, 96–97, 99, 114, 146–151, 158–160, 165–173, 175–176, 178, 180–183, 186, 188–194, 212–213
urban areas
146, 149–151, 155
US cities
147, 158–159
value based healthcare (VBHC)
1–2, 99, 104–109, 114, 116–119
value chain
182–184, 193–194
zoonoses
53, 65, 69
zoonotic foodborne diseases
1, 52–53, 62–63, 65, 214
zoonotic foodborne pathogens
53–54, 60